Jeffrey Eisele
Corporate Officer/Principal presso APELLIS PHARMACEUTICALS, INC.
Patrimonio netto: 3 M $ in data 30/04/2024
Profilo
Jeffrey Eisele is currently the Chief Development Officer at Apellis Pharmaceuticals, Inc. Prior to this, he worked at Novartis, Inc. as the VP-Global Biostatistics & Head-Neuroscience.
He completed his undergraduate degree at George Washington University and his graduate and doctorate degrees at the University of Michigan.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
30/01/2024 | 57 208 ( 0.05% ) | 3 M $ | 30/04/2024 |
Posizioni attive di Jeffrey Eisele
Società | Posizione | Inizio |
---|---|---|
APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Jeffrey Eisele
Società | Posizione | Fine |
---|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Corporate Officer/Principal | - |
Formazione di Jeffrey Eisele
George Washington University | Undergraduate Degree |
University of Michigan | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
APELLIS PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey Eisele